Related Experiment Videos
[Proliferative vitreoretinopathy treated with daunorubicin]
1Department of Ophthalmology, Kyorin University School of Medicine, Japan.
Nippon Ganka Gakkai Zasshi
|August 1, 1997
Summary
Daunorubicin infusion after vitrectomy helped reattach retinas in proliferative vitreoretinopathy. While effective in preventing reproliferation, careful monitoring for complications like conjunctival dehiscence is crucial.
Area of Science:
- Ophthalmology
- Retinal Surgery
Context:
- Severe proliferative vitreoretinopathy presents a significant challenge in retinal detachment surgery.
- Preventing reproliferation is crucial for long-term surgical success.
Purpose:
- To evaluate the efficacy of Daunorubicin infusion in preventing reproliferation after vitrectomy for severe proliferative vitreoretinopathy.
- To assess the overall success rate of retinal reattachment and identify postoperative complications.
Summary:
- Nine eyes with severe proliferative vitreoretinopathy underwent vitrectomy with Daunorubicin infusion.
- Initial retinal reattachment was achieved in 56% of eyes; redetachment occurred in 4 eyes due to reproliferation or incomplete sealing.
- All eyes eventually achieved complete retinal reattachment after a second vitrectomy, with one case requiring silicone oil tamponade.
Impact:
- Daunorubicin demonstrated effectiveness in suppressing retinal reproliferation.
- Postoperative complications included conjunctival dehiscience (3 eyes) and orbital cellulitis (1 eye).
- Careful management is necessary to mitigate potential postoperative complications associated with this treatment approach.